|
IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma |
|
|
|
Titel: |
IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma |
Auteur: |
Fei, Keke Ni, Haiqing Zhu, Mengjia Kuang, Zhihui Wu, Min Wu, Zhihai Wang, Feifei Zhou, Shuaixiang Jing, Hua Wu, Weiwei Wu, Dongdong Bai, Dongmei Chen, Bingliang |
Verschenen in: |
Cancer letters |
Paginering: |
Jaargang 536 () nr. C pagina's p. |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|